Slide 1: Third Quarter 2025 Earnings
Third Quarter 2025 Earnings EARNINGS PRESENTATION October 29, 2025
Slide 2: Forward Looking Statements, Non-GAAP Financial Measures, & Basis of Presentation
Forward Looking Statements, Non-GAAP Financial Measures, & Basis of Presentation FORWARD-LOOKING STATEMENTS Statements in this presentation that are not strictly historical, including statements regarding anticipated financial results, global and regional economic conditions, industry trends, geopol
Slide 3: Key Messages
Key Messages 1 Strong execution in our first quarter as new Fortive with solid performance across all key financial metrics Raising FY adjusted EPS guidance to $2.63 to $2.67, 2 reflecting strong Q3 Adj. EPS performance $1B of share repurchases in Q3 underscores our 3 commitment to disciplined capit
Slide 4: Fortive Accelerated
Fortive Accelerated Faster, Profitable Organic Growth Powered by FBS Amplified Capital Allocation • Clear priorities to invest in organic growth, • New product velocity beginning to accelerate as a result of renewed focus on pursue accretive bolt-on M&A, return capital customer-centric innovation. Q
Slide 5: Fortive Results
Fortive Results Q3 2025, Continuing Operations COMMENTARY Q3 2025 • Core growth of ~2% reflects growth at both segments amidst dynamic market Revenue $1,027M conditions; sequential improvement in Reported Growth +2.3% North America, partially offset by macro Core Growth +1.9% weakness in Europe Adj.
Slide 6: Intelligent Operating Solutions
Intelligent Operating Solutions Q3 2025, Continuing Operations Q3 2025 COMMENTARY • Revenue growth driven by strength in Revenue $699M FAL software, professional Reported Growth +2.6% instrumentation, and gas detection, Core Growth +2.2% partially offset by continued government pressure in construct
Slide 7: Advanced Healthcare Solutions
Advanced Healthcare Solutions Q3 2025, Continuing Operations Q3 2025 COMMENTARY • Revenue growth driven by continued Revenue strength in resilient, SaaS-based $328M Reported Growth +1.9% healthcare software Core Growth +1.1% • Sequential improvement in healthcare equipment demand in North America, d
Slide 8: Balance Sheet & Capital Allocation
Balance Sheet & Capital Allocation Q3 2025 COMMENTARY Balance Sheet As of September 26, 2025 • $1B capital deployed towards share Cash and equivalents $0.4B repurchase in the quarter; repurchased Gross debt $3.3B ~21M shares at an average price of ~$48 per share Net debt $2.9B • Ample capacity and f
Slide 9: Guidance
Guidance As of Q3 2025, Continuing Operations Adj. EPS | FY 2025 $2.63 - $2.67 • Guidance raised by $0.10 at the midpoint, reflecting Q3 outperformance • Assumes current demand environment continues through the rest of 2025 • Includes net impact of current or known future tariffs expected through th
Slide 10: Fortive Accelerated
Fortive Accelerated Innovating essential technologies to keep our world safe and productive 10
Slide 11: Supplemental Reconciliation Data
Supplemental Reconciliation Data 11
Slide 12: Core Revenue Growth
CORE REVENUE GROWTH Three Months Ended Components of Revenue Growth September 26, 2025 September 27, 2024 Intelligent Advanced Intelligent Advanced Operating Healthcare Total Fortive Operating Healthcare Total Fortive Solutions Solutions Solutions Solutions Total revenue growth (GAAP) 2.6 % 1.9 % 2.
Slide 13: Adjusted Gross Profit and Adjusted Gross Profit Margin
ADJUSTED GROSS PROFIT AND ADJUSTED GROSS PROFIT MARGIN Three Months Ended September 26, 2025 Three Months Ended September 27, 2024 $ in millions Intelligent Advanced Total Intelligent Advanced Total Operating Healthcare Fortive Operating Healthcare Fortive Solutions Solutions Solutions Solutions Rev
Slide 14: Adjusted EBITDA and Adjusted EBITDA Margin from Continuing Operations
ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN FROM CONTINUING OPERATIONS Three Months Ended $ in millions September 26, 2025 September 27, 2024 Revenue (GAAP) $ 1,027.1 $ 1,003.7 Net Earnings from Continuing Operations (GAAP) $ 117.0 $ 111.5 Interest expense, net 25.4 37.1 Income taxes 18.0 (2.4) Depre
Slide 15: Operating Profit to Adjusted EBITDA and Adjusted Margin Bridge
FORTIVE CONTINUING OPERATIONS: OPERATING PROFIT & OPERATING PROFIT MARGIN TO ADJUSTED EBITDA AND ADJUSTED MARGIN BRIDGE Three Months Ended $ in millions September 26, 2025 September 27, 2024 Revenue (GAAP) $ 1,027.1 $ 1,003.7 Operating Profit (GAAP) $ 159.6 $ 172.0 Amortization of acquisition-relate
Slide 16: Segment Adjusted EBITDA and Segment Adjusted EBITDA Margin
SEGMENT ADJUSTED EBITDA AND SEGMENT ADJUSTED EBITDA MARGIN Three Months Ended September 26, 2025 Three Months Ended September 27, 2024 $ in millions Intelligent Advanced Corporate Total Intelligent Advanced Corporate Total Operating Healthcare Fortive Operating Healthcare Fortive Solutions Solutions
Slide 17: Adjusted Net Earnings and Adjusted Diluted Net EPS
ADJUSTED NET EARNINGS AND ADJUSTED DILUTED NET EPS FROM CONTINUING OPERATIONS Three Months Ended $ in millions, except per share amounts September 26, 2025 September 27, 2024 Per share Per share value value Net Earnings and Net Earnings Per Share from Continuing Operations (GAAP) $ 117.0 $ 0.35 $ 11
Slide 18: Free Cash Flow from Continuing Operations - Trailing Twelve Months
FREE CASH FLOW FROM CONTINUING OPERATIONS - TRAILING TWELVE MONTHS (in millions) Three Months Ended Trailing Twelve September 26, 2025 June 27, 2025 March 28, 2025 December 31, 2024 Months Operating Cash Flows (GAAP) $ 294.7 $ 205.0 $ 191.8 $ 327.7 $ 1,019.2 Less: Purchases of property, plant & equi
Slide 19: Disaggregation of Revenue - Total Fortive
DISAGGREGATION OF REVENUE - TOTAL FORTIVE Three Months Ended Year Ended Three Months Ended Year Ended Three Months Ended $ in millions March 31, June 30, September 29, December 31, December 31, March 29, June 28, September 27, December 31, December 31, March 28, June 27, September 26, 2023 2023 2023
Slide 20: Disaggregation of Revenue - Segments
DISAGGREGATION OF REVENUE - SEGMENTS Three Months Ended Year Ended Three Months Ended Year Ended Three Months Ended $ in millions March 31, June 30, September 29, December 31, December 31, March 29, June 28, September 27, December 31, December 31, March 28, June 27, September 26, 2023 2023 2023 2023
Slide 21: @FORTIVE © Fortive 2025
@FORTIVE © Fortive 2025 2